Why Stack CJC-1295 Specifically?

Among the growth hormone peptides available for stacking with GLP-1 medications, CJC-1295 stands out for its duration of action. While sermorelin requires nightly injections and produces brief GH pulses, CJC-1295 (especially the DAC form) provides sustained GH elevation that can last days from a single injection.

This makes CJC-1295 particularly attractive for patients who:

• Want fewer total injections per week
• Prefer consistent, around-the-clock GH support rather than overnight-only pulses
• Are already committed to weekly semaglutide injections and want a simple add-on schedule
• Have tried shorter-acting peptides and want a more sustained option

The trade-off is that CJC-1295 with DAC is harder to dose-adjust quickly (its effects linger for days), and it carries a slightly higher risk of water retention. These are manageable considerations, not dealbreakers. peptide therapy options

Stack Components in Detail

Semaglutide: The Weight Loss Engine

• Type: GLP-1 receptor agonist
• Mechanism: Appetite suppression, slowed gastric emptying, improved insulin sensitivity
• Dose range: 0.25 to 2.4 mg weekly
• Half-life: ~7 days
• Administration: Subcutaneous injection, once weekly
• Clinical weight loss: 12 to 17% of body weight average in trials

From $299

CJC-1295: The Growth Hormone Foundation

• Type: GHRH analog (with or without DAC)
• Mechanism: Stimulates pituitary GH release through GHRH receptors
• Dose range: 1 to 2 mg weekly (DAC) or 100 to 300 mcg per dose (no DAC)
• Half-life: 6 to 8 days (DAC) or ~30 minutes (no DAC)
• Administration: Subcutaneous injection
• Primary benefits: Muscle preservation, sleep enhancement, fat metabolism, recovery

Contact provider for current pricing

Building Your Stack: Complete Roadmap

Pre-Stack: Medical Evaluation

Every stack begins with a comprehensive evaluation:

• Complete health history review
• Current medication and supplement assessment
• Contraindication screening (active cancer, MTC history, pituitary disorders)
• Baseline labs: CMP, HbA1c, IGF-1, lipid panel, thyroid function, CBC
• Body composition measurement (DEXA preferred)
• Goal setting and protocol discussion

medical evaluation at Form Blends

Week 1: Start Semaglutide

Begin semaglutide at 0.25 mg weekly. This introductory dose lets your GI system adapt. Most patients experience mild nausea that improves within 1 to 2 weeks. Focus on hydration and eating small, protein-focused meals.

Week 5: Increase Semaglutide

Move to 0.5 mg weekly if the introductory dose was well tolerated. Appetite suppression and early weight loss typically begin at this dose. Continue monitoring GI symptoms.

Weeks 6 to 8: Introduce CJC-1295

Once semaglutide is stable at 0.5 mg or higher for 2+ weeks, add CJC-1295:

• DAC form: Start at 1 mg, once weekly. Assess tolerance over 2 to 3 weeks before considering dose increase.
• No-DAC form: Start at 100 mcg, once nightly at bedtime on empty stomach. Increase to 200 to 300 mcg over 2 weeks as tolerated.

Weeks 10 to 12: First Lab Check

Draw IGF-1, fasting glucose, and CMP. These results guide dose optimization for CJC-1295 and confirm glucose stability.

Month 3 Onward: Optimize and Monitor

Continue titrating semaglutide upward as needed (1.0 mg, 1.7 mg, up to 2.4 mg). Maintain CJC-1295 at the established dose. Recheck labs every 3 months. Adjust based on IGF-1, glucose, body composition data, and clinical response.

Dosing Quick Reference

Timing and Injection Management

CJC-1295 with DAC Timing

Because of its extended half-life, CJC-1295 with DAC is flexible on timing. Many patients find it convenient to inject on the same day as semaglutide, using a different injection site and different syringe. Morning injections are common since there is no fasting requirement with the DAC form.

CJC-1295 without DAC Timing

The no-DAC form is time-sensitive:

• Primary dose: Bedtime, at least 2 hours after last meal (food, especially carbs and fat, suppresses the GH response)
• Optional second dose: Upon waking, before breakfast (fasted)
• Optional third dose: 30 to 60 minutes before exercise (fasted or near-fasted)

Injection Site Rotation

Rotate among abdomen (2+ inches from navel), front of thigh, and back of upper arm. Never inject two medications at the same site on the same day. Keep a simple injection log to track rotation.

Expanding the Stack: Add-On Peptides

Once the base CJC-1295 and semaglutide stack is stable (typically 8 to 12 weeks in), some protocols add complementary peptides:

The CJC-1295 plus ipamorelin combination is one of the most widely used peptide stacks in clinical practice. Ipamorelin triggers acute GH release while CJC-1295 provides the GHRH signal that amplifies and sustains it. When paired with semaglutide, this creates a three-component stack with excellent body composition potential. ipamorelin therapy

We recommend keeping the stack as simple as possible. Each additional component adds cost, complexity, and monitoring requirements. Master the base stack before expanding.

Cycling Your CJC-1295

CJC-1295 with DAC

Cycling is generally recommended due to sustained receptor stimulation. Common patterns:

• 8 weeks on, 4 weeks off
• 12 weeks on, 4 weeks off

During the off period, some patients substitute sermorelin (shorter-acting) to maintain some GH support without continuous GHRH receptor stimulation.

CJC-1295 without DAC

Less strict cycling is needed due to the shorter half-life. Options:

• 5 days on, 2 days off each week
• Continuous dosing with quarterly IGF-1 monitoring to guide breaks if needed

Semaglutide

Not cycled. Used continuously through the weight loss phase, then tapered for maintenance.

Nutrition Strategy

Your nutrition determines whether the stack reaches its potential:

Protein

This is the most important macronutrient for this stack. Target 0.7 to 1.0 grams per pound of target body weight. Without sufficient protein, even optimized GH levels cannot fully protect lean muscle. High-protein foods include chicken breast, fish, eggs, Greek yogurt, lean beef, and whey protein.

Meal Timing

• If using CJC-1295 no DAC at bedtime: stop eating 2+ hours before injection
• Eat smaller, more frequent meals to manage semaglutide GI effects
• Front-load calories earlier in the day if evening fasting is challenging

Hydration

Especially important with this stack. CJC-1295 DAC can cause mild water retention, and semaglutide's GI effects are worsened by dehydration. Aim for at least half your body weight in ounces of water daily.

Exercise Framework

• Resistance training (3 to 4x/week): The single most impactful exercise for this stack. Compound movements (squats, deadlifts, presses, rows) stimulate the most muscle groups and trigger additional natural GH release.
• Moderate cardio (2 to 3x/week): Walking, cycling, swimming. 20 to 40 minutes. Avoid excessive endurance training during significant caloric restriction.
• Recovery focus: CJC-1295 supports recovery, but allow 48 hours between resistance sessions targeting the same muscle groups. Sleep is your top recovery tool.

Expected Results Timeline

Common Mistakes

• Starting CJC-1295 DAC at too high a dose. The long half-life means side effects persist. Start low.
• Eating before CJC-1295 no-DAC injection. Blunts the GH response significantly.
• Neglecting protein intake. The number one nutrition mistake. Track it.
• Skipping labs. IGF-1 monitoring is essential, especially with CJC-1295 DAC.
• Expecting scale weight to tell the whole story. Body composition is what matters. Use DEXA scans or measurements, not just scale weight.
• Not rotating injection sites. Leads to tissue irritation and inconsistent absorption.
• Adjusting doses without physician guidance. Both medications require clinical oversight for changes.

Frequently Asked Questions

Is CJC-1295 legal?

CJC-1295 is a prescription peptide available through compounding pharmacies. When prescribed by a licensed physician based on a medical evaluation, its use is legal. It is not an FDA-approved medication but is available under compounding regulations.

How does the cost compare to a sermorelin-semaglutide stack?

Costs vary by pharmacy, dose, and form. CJC-1295 with DAC may cost more per vial but requires fewer doses. CJC-1295 without DAC is often priced comparably to sermorelin. Our team provides specific pricing during consultation. Contact provider for current pricing

Can women use this stack?

Yes. This stack is appropriate for both men and women. Dosing is individualized. Women who are pregnant, breastfeeding, or planning pregnancy should not use either medication.

What if I am already on sermorelin and want to switch to CJC-1295?

Your physician can manage the transition. Typically, you would stop sermorelin and begin CJC-1295 in the same or following week. No washout period is needed since both target the same receptor pathway. Semaglutide continues unchanged throughout the switch.

Can I combine CJC-1295 with DAC and CJC-1295 without DAC?

This is uncommon and generally unnecessary. Choose one form or the other. Using both adds complexity without clear benefit.

How long can I safely stack these medications?

Semaglutide can be used for 12+ months continuously. CJC-1295 is typically used in cycles (8 to 12 weeks on, 4 weeks off for DAC; more flexible for no-DAC). Your physician determines duration based on your progress and goals.

Stack with Confidence

The CJC-1295 and semaglutide stack offers sustained growth hormone support paired with one of the most effective weight loss medications available. Whether you choose the convenience of CJC-1295 with DAC or the pulsatile precision of the no-DAC form, you are building a stack designed to help you lose fat, keep muscle, sleep better, and recover faster. At Form Blends, our physicians design, prescribe, and manage this stack from your first consultation through your last lab check. start your consultation with Form Blends